Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-19 Purchase | 2024-08-19 3:45 pm | KIORA PHARMACEUTICALS INC | KPRX | TYLE PRAVEEN Director | 5,000 | $3.96 | $19,800 | 5,014 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-01 Option Award | 2024-07-03 3:15 pm | 2025-07-01 2034-07-01 | KIORA PHARMACEUTICALS INC | KPRX | TYLE PRAVEEN Director | 1,778 | $0 | 1,778 (Direct) | View |
2024-02-29 Option Award | 2024-03-04 06:20 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 35,000 | $0 | 35,000 (Direct) | View |
2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 14,110 | $0 | 20,001 (Direct) | View |
2023-09-29 Option Award | 2023-10-03 4:46 pm | N/A 2033-09-29 | KIORA PHARMACEUTICALS INC | KPRX | TYLE PRAVEEN Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-08-25 Option Award | 2023-08-29 6:22 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 1,472,692 | $0 | 1,472,692 (Direct) | View |
2023-03-03 Option Award | 2023-03-07 8:14 pm | N/A 2033-03-03 | KIORA PHARMACEUTICALS INC | KPRX | TYLE PRAVEEN Director | 8,000 | $0 | 8,000 (Direct) | View |
2023-01-05 Option Award(A) | 2023-01-09 11:28 am | N/A 2033-01-05 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 250,000 | $0 | 250,000 (Direct) | View |
2023-01-05 Option Award | 2023-01-06 5:21 pm | N/A 2033-01-05 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 250,000 | $0 | 250,000 (Direct) | View |
2022-02-01 Option Award | 2022-02-03 7:06 pm | N/A 2032-02-01 | KIORA PHARMACEUTICALS INC | KPRX | TYLE PRAVEEN Director | 5,000 | $0 | 5,000 (Direct) | View |
2021-09-14 Option Award | 2021-09-16 4:01 pm | N/A 2031-09-14 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 25,000 | $0 | 275,000 (Direct) | View |
2021-07-22 Option Award | 2021-07-26 2:23 pm | N/A 2031-07-22 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 250,000 | $0 | 250,000 (Direct) | View |
2021-02-28 Tax Withholding | 2021-03-02 5:00 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D | 16,560 | $7.19 | 204,771 (Direct) | View |
2021-02-28 Exercise | 2021-03-02 5:00 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D | 68,007 | $0 | 204,771 (Direct) | View |
2021-02-11 Option Award | 2021-02-16 4:41 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D | 128,410 | $0 | 128,410 (Direct) | View |
2021-02-01 Option Award | 2021-02-03 9:53 pm | N/A 2031-02-01 | EYEGATE PHARMACEUTICALS INC | EYEG | TYLE PRAVEEN Director | 3,333 | $0 | 3,333 (Direct) | View |
2020-04-22 Tax Withholding | 2020-04-24 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D | 4,844 | $1.96 | 69,344 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:20 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D | 19,893 | $0 | 69,344 (Direct) | View |
2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D | 39,316 | $0 | 120,212 (Direct) | View |
2020-02-14 Option Award | 2020-02-19 4:32 pm | N/A 2030-02-14 | EYEGATE PHARMACEUTICALS INC | EYEG | TYLE PRAVEEN Director | 3,333 | $0 | 3,333 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:14 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D | 344,280 | $0 | 344,280 (Direct) | View |